{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:20Z","timestamp":1791357200580,"version":"4.3.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1097\/chi.0b013e31802ed8b2","type":"journal-article","created":{"date-parts":[[2007,2,13]],"date-time":"2007-02-13T04:00:51Z","timestamp":1171339251000},"page":"356-361","source":"Crossref","is-referenced-by-count":27,"title":["Case Report"],"prefix":"10.1016","volume":"46","author":[{"given":"TERI","family":"CARLSON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CHARLES A.","family":"REYNOLDS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROCHELLE","family":"CAPLAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/chi.0b013e31802ed8b2_bib1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1089\/cap.2005.15.520","article-title":"Risperidone-induced psychosis and depression in a child with a mitochondrial disorder","volume":"15","author":"Ahn","year":"2005","journal-title":"J Child Adolesc Pyschopharmacol"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00004583-200206000-00002","article-title":"Valproic acid and risperidone","volume":"41","author":"Bertoldo","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1651-2227.1996.tb14058.x","article-title":"The effect of carnitine supplementation in valproate-induced hyperammonemia","volume":"85","author":"Boehles","year":"1996","journal-title":"Acta Paediatr"},{"issue":"Suppl 1","key":"10.1097\/chi.0b013e31802ed8b2_bib4","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1177\/088307380401900104","article-title":"Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients","volume":"19","author":"Glauser","year":"2004","journal-title":"J Child Neurol"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib5","first-page":"204","article-title":"Pharmacokinetic interactions and side effects resulting from concomitant administration of lithium and divalproex sodium","volume":"57","author":"Granneman","year":"1996","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib6","series-title":"Child and Adolescent Clinical Psychopharmacology","author":"Green","year":"2001"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00441418","article-title":"Hyperamino-acidemia and hyperammonemia in epileptic children treated with valproic acid","volume":"148","author":"Iinuma","year":"1988","journal-title":"Eur J Pediatr"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004850-200501000-00012","article-title":"Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting","volume":"20","author":"Kimmel","year":"2005","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib9","first-page":"235","article-title":"A study on valproate-induced hyperammonemia","volume":"47","author":"Komatsu","year":"1986","journal-title":"Med J Kobe Univ"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib10","first-page":"663","article-title":"Blood ammonia level during valproic acid therapy","volume":"40","author":"Kugoh","year":"1986","journal-title":"Jpn J Psychiatry Neurol"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1528-1157.1986.tb03501.x","article-title":"Nutritional influence on serum ammonia in young patients receiving sodium valproate","volume":"27","author":"Laub","year":"1986","journal-title":"Epilepsia"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib12","first-page":"314","article-title":"Hyperammonemia during valproic-acid therapy in pediatric patients","volume":"57","author":"Laub","year":"1986","journal-title":"Nervenarzt"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1528-1157.1986.tb03584.x","article-title":"Serum carnitine during valproic-acid therapy","volume":"27","author":"Laub","year":"1986","journal-title":"Epilepsia"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/clpt.1990.144","article-title":"Effects of polytherapy with phenytoin, carbamazepine, and stiripentol? On formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid","volume":"48","author":"Levy","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib15","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1345\/aph.1E063","article-title":"Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman","volume":"38","author":"Mallet","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1212\/WNL.38.3.365","article-title":"Hepatic and renal contributions to valproic acid-induced hyperammonemia","volume":"38","author":"Marini","year":"1988","journal-title":"Neurology"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib17","doi-asserted-by":"crossref","first-page":"555","DOI":"10.4088\/JCP.v66n0502","article-title":"Carnitine levels in valproic acid-treated psychiatric patients: a cross-sectional study","volume":"66","author":"Moreno","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archneur.1982.00510210061016","article-title":"Asymptomatic hyperammonemia in patients receiving valproic-acid","volume":"39","author":"Murphy","year":"1982","journal-title":"Arch Neurol"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib19","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","article-title":"Carnitine deficiency and hyperammonemia associated with valproic-acid therapy","volume":"101","author":"Ohtani","year":"1982","journal-title":"J Pediatr"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0924-977X(98)00040-6","article-title":"Drug metabolism and atypical antipsychotics","volume":"9","author":"Prior","year":"1999","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00002512-200320020-00005","article-title":"Drug treatment of epilepsy in elderly people: focus on valproic acid","volume":"20","author":"Stephen","year":"2003","journal-title":"Drugs Aging"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004583-200301000-00001","article-title":"Valproic acid and risperidone: a drug interaction [letter]","volume":"42","author":"Sund","year":"2003","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib23","first-page":"71","article-title":"Hyperammonemia and abnormal nitrogen metabolism caused by anticonvulsants with special reference to epileptic with severe physical and mental disturbances","volume":"85","author":"Takei","year":"1983","journal-title":"Psychiatr Neurol Jpn"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib24","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00004583-200108000-00003","article-title":"Valproic acid and risperidone","volume":"40","author":"Van Wattum","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0773.1996.tb00247.x","article-title":"Lithium and valproate combined administration: acute behavioural effects and drug plasma levels","volume":"79","author":"Vargas","year":"1996","journal-title":"Pharmacol Toxicol"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s005990050060","article-title":"Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anitconvulsant drugs","volume":"29","author":"Verrotti","year":"1999","journal-title":"Int J Clin Lab Res"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/S0890-8567(09)60329-4","article-title":"Valproic acid and risperidone","volume":"40","author":"Vitiello","year":"2001","journal-title":"J Child Adolesc Psychiatry"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib28","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1097\/00004714-199202001-00010","article-title":"Pharmacokinetics of valproate and carbamazepine","volume":"12","author":"Wilder","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"10.1097\/chi.0b013e31802ed8b2_bib29","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0006-2952(99)00173-2","article-title":"Inhibitory effect of valproate on weak organic acid uptake in rat renal proximal tubules","volume":"58","author":"Zagryadskaya","year":"1999","journal-title":"Biochem Pharmacol"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709616798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856709616798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T06:46:11Z","timestamp":1568184371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856709616798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0890856709616798"],"URL":"https:\/\/doi.org\/10.1097\/chi.0b013e31802ed8b2","relation":{},"ISSN":["0890-8567"],"issn-type":[{"value":"0890-8567","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}